论文部分内容阅读
目的观察尤瑞克林治疗急性脑梗死的临床疗效。方法将符合入选条件的80例急性脑梗死患者分为治疗组和对照组,每组40例。两组基础治疗相似,治疗组患者加用尤瑞克林,1次/d;分别给予治疗前后神经功能缺损评分和临床疗效比较,28d后复查影像学检查。结果治疗组神经功能缺损评分较治疗前差异有统计学意义(P<0.05),疗效明显优于对照组,且无不良反应。结论尤瑞克林治疗急性脑梗死疗效确切,安全可靠。
Objective To observe the clinical efficacy of urelin in the treatment of acute cerebral infarction. Methods Eighty patients with acute cerebral infarction who met the inclusion criteria were divided into treatment group and control group, 40 cases in each group. The two groups of similar basic treatment, the treatment group plus uracil, 1 / d; respectively, before and after treatment of neurological deficit score and clinical efficacy comparison, 28 days after the review imaging studies. Results The score of neurological deficit in the treatment group was significantly higher than that before treatment (P <0.05), and the curative effect was obviously better than that of the control group with no adverse reactions. Conclusion The efficacy of urelin in the treatment of acute cerebral infarction is accurate, safe and reliable.